Regorafenib shows early promise in colorectal candidates unable to undergo chemo

Genomic sequencing helps identify best candidates for adjuvant chemo in colorectal cancer

First-line bevacizumab plus chemo and cetuximab plus chemo provide similar survival benefits in metastatic colorectal cancer

First-line bevacizumab plus chemotherapy and cetuximab plus chemotherapy provide similar survival benefit for patients with metastatic colorectal cancer

Role of AORTIC in dealing with rising cancer rates in Africa

Coffee as a preventative measure against liver cancer

The relationship between obesity and cancer, and other dietary factors

Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703

ecancermedicalscience Editor's Choice for January 2014

Goals of 1st Indian Cancer Congress

Cancer cells and the immune system: a natural story?

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction